The leader in developing and commercializing innovative biomarker products and services
Rules-Based Medicine (RBM) uses proprietary Multi-Analyte Profiling (MAP) technology to make life science research and drug and diagnostic development programs more efficient and effective. Whether measuring hundreds of biomarkers or simply a few, our approach provides reproducible, quantitative immunoassay data from a small sample volume at a cost-effective price. RBM is CLIA certified and supports GLP studies.
Life Science ResearchIdentify novel biomarker patterns by "Casting a Wide Net" using the RBM approach to biomarker pattern discovery. Take advantage of cross species analysis capabilities using a single, validated platform to interrogate multiple homologuous proteins in human, primate, mouse and rat samples.
 |
Drug DevelopmentRBM's tests are validated to meet or exceed clinical laboratory standards. These processes enable us to reproducibly extend biomarker pattern discoveries made in preclinical research forward into human clinical trials. The use of sensitive, reproducible biomarker patterns will maximize your development efforts.
|
